Volume 65, Issue 5 , Pages 1289-1299, 1 August 2006
Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis
Heterotopic ossification (HO) is a benign condition of abnormal formation of bone in soft tissue. HO is frequently asymptomatic, though when it is more severe it typically manifests as decreased range of motion at a nearby joint. HO has been recognized to occur in three distinct contexts—trauma, neurologic injury, and genetic abnormalities. The etiology of HO is incompletely understood. A posited theory is that HO results from the presence of osteoprogenitor cells pathologically induced by an imbalance in local or systemic factors. Individuals at high risk for HO development frequently undergo prophylaxis to prevent HO formation. The two most commonly employed modalities for prophylaxis are nonsteroidal anti-inflammatory drugs and radiation therapy. This review discusses HO pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.
Keywords: Heterotopic ossification , Heterotopic bone , Radiation therapy , Prophylaxis
To access this article, please choose from the options below
PII: S0360-3016(06)00679-1
doi:10.1016/j.ijrobp.2006.03.053
© 2006 Elsevier Inc. All rights reserved.
Volume 65, Issue 5 , Pages 1289-1299, 1 August 2006
